Skip to main content
. Author manuscript; available in PMC: 2013 Oct 21.
Published in final edited form as: Curr Opin Infect Dis. 2011 Feb;24(1):34–42. doi: 10.1097/QCO.0b013e3283420f76

Figure 1.

Figure 1

Graph showing the probability of survival without death or development of an AIDS-defining illness in the randomised controlled trial comparing ART initiation within 14 days of starting treatment for acute opportunistic infections (excluding tuberculosis) versus delayed ART until after completion of the opportunistic infection. Graph adapted from Zolopa et al., 2009 [29**].